Navigation Links
PharmAthene Reports Third Quarter 2011 Financial and Operating Results
Date:11/9/2011

ributable to common shareholders was $0.03 million, or $0.00 per share, compared to $4.3 million, or $0.14 per share, in the same period of 2010.  The year-over-year decrease in net loss includes the impact of the change in fair value of the Company's derivative instruments, which resulted in a non-cash decrease of expenses of $2.9 million for the three months ended September 30, 2011 compared to a non-cash decrease of expenses of $0.08 million for the same period in 2010. The decrease in fair value realized during the third quarter of 2011 was primarily the result of the decrease in PharmAthene's stock price from $2.94 per share on June 30, 2011 to $1.76 per share on September 30, 2011.

As of September 30, 2011, the Company had cash and cash equivalents, short-term investments, and net U.S. government accounts receivables and other receivables, including unbilled receivables, totaling approximately $16.9 million compared to $21.6 million at December 31, 2010.  The decrease at September 30, 2011 was primarily due to a combination of a loss from operations of $10.6 million, partially offset by proceeds from a registered direct public offering of common stock and warrants completed in June 2011, which raised net proceeds for the Company of $5.8 million, as well as a net reduction in receivables, prepaid expenses and other current assets and noncash expenses."During the quarter we made significant progress across our biodefense countermeasures programs, particularly in our development of our second generation anthrax vaccine, SparVax™," continued Mr. Richman.  "We recently completed the first 1,500 cGMP manufacturing production run as part of the development of a robust manufacturing process.  This is a significant achievement for our Company and enables us to potentially produce more than 150 million rPA vaccine equivalent doses of bulk drug substance at a 50 mcg dose.  We were also awarded a contract valued at $5.7 million
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. PharmAthene Progresses Second Generation rPA Anthrax Vaccine
2. PharmAthene Appoints Brian A. Markison to the Companys Board of Directors
3. PharmAthene Achieves Significant Progress in SparVax™ Anthrax Vaccine Program
4. Department of Defense Awards $5.7 Million Contract to PharmAthene for Nerve Agent Medical Countermeasure Program
5. PharmAthene Selected for Inclusion in the Russell Global Index and Russell 3000 Index
6. PharmAthene Achieves Anthrax Vaccine Program Milestone and Successfully Completes Technology Transfer
7. PharmAthene Completes $6.5 Million Registered Direct Offering
8. PharmAthene Reports First Quarter 2011 Financial and Operating Results
9. PharmAthene to Host Year-End 2010 Earnings Conference Call and Webcast on Monday, March 28, 2011
10. PharmAthene Strengthens Scientific Leadership and Program Management for Future Growth
11. PharmAthene Receives FDA Clearance to Reinitiate Clinical Testing of Valortim®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... Nasa Ames Research Base, Mountain View, CA (PRWEB) September ... announces the launch of its fundraising campaign on Indiegogo. ... producer Matt Rutherford, features Stephen Hawking, Buzz Aldrin, Shimon ... , Exponential technology is changing the world and there’s ... students how to harness it to help change the ...
(Date:9/11/2014)... it has uncovered the secret behind the unusual ... metal dichalcogenide (TMDC) materials, the two-dimensional semiconductors that ... , Using two-photon excitation spectroscopy, the researchers ... most promising of 2D materials, and found evidence ... energy states in which single photons can be ...
(Date:9/11/2014)... SARASOTA, Fla. , Sept. 11, 2014 ... novel anti-infective pharmaceuticals, announced today that the ... issued a ,Notice of Allowance, for patent ... Their Uses,.  The ,486 patent application relates ... act through gene-silencing and can be designed ...
(Date:9/11/2014)... TORONTO , Sept. 11, 2014 /PRNewswire/ - Portage ... Canadian Securities Exchange: PBT.U), announces that it intends ... to US$ 2 million for funding its preclinical ... Holding Company Limited, ("Biohaven"). The Company ... up to 20 million common shares at a ...
Breaking Biology Technology:Documentary Film that Follows Singularity University Students as They Change the World Launches its IndieGoGo Fundraising Campaign 2Excitonic dark states shed light on TMDC atomic layers 2Excitonic dark states shed light on TMDC atomic layers 3Lakewood-Amedex Receives Notice Of Allowance From The United States Patent and Trademark Office (USPTO) For A New Patent Covering Its nanoRNA Gene-Silencing Technology 2Lakewood-Amedex Receives Notice Of Allowance From The United States Patent and Trademark Office (USPTO) For A New Patent Covering Its nanoRNA Gene-Silencing Technology 3Portage Announces Proposed Private Placement 2Portage Announces Proposed Private Placement 3Portage Announces Proposed Private Placement 4
... Halozyme Therapeutics,Inc. (Nasdaq: HALO ), a biopharmaceutical ... that it will present at two investor conferences in ... Summit to be held at the,Mark Hopkins InterContinental Hotel ... a.m. Pacific Time (12:30 p.m. Eastern Time); and, ...
... Masimo (Nasdaq:,MASI), the inventor of Pulse CO-Oximetry ... purchasing the Masimo Radical-7, the company,s flagship,product, ... as a standard feature., Conventional pulse ... drops in oxygen saturation values, known as ...
... Washington, DC Widespread use of nanoscale silver ... benefits against the possibility of significant environmental risk, ... this emerging technology, according to a new report ... (PEN). , But existing information about the ...
Cached Biology Technology:Halozyme Therapeutics to Present at Upcoming Investor Conferences 2Masimo Announces Desaturation Index 3D Alarm as Standard Feature in All Radical-7 Pulse CO-Oximetry Devices 2Masimo Announces Desaturation Index 3D Alarm as Standard Feature in All Radical-7 Pulse CO-Oximetry Devices 3Nanoscale silver: No silver lining? 2Nanoscale silver: No silver lining? 3
(Date:9/12/2014)... dendritic cells in human skin have assorted functions in ... researchers in the journal EMBO Molecular Medicine . ... composition of dendritic cells in psoriatic skin lesions might ... disease. , "We urgently need new ways to ... patients and reduce the incidence of known side effects ...
(Date:9/11/2014)... The classical treatise "Flora of Northumberland and Durham" ... Advanced Books platform as an example of ... create a new sort of resource and data re-use. ... botany of the region, which can be seen as ... on-line semantically enriched re-publication marries the meticulous detail ...
(Date:9/11/2014)... of DDT, American peregrine falcons ( Falco peregrines anatum ... to stop rearing young birds in captivity and placing ... published models that year in ESA,s journal ... falcon in California, with and without direct human intervention ... birds would continue to recover without captive rearing, though ...
Breaking Biology News(10 mins):Dendritic cells affect onset and progress of psoriasis 2Re-publication of 'Flora of Northumberland and Durham' (1831): A dramatic account of change 2Re-publication of 'Flora of Northumberland and Durham' (1831): A dramatic account of change 3Volunteer 'eyes on the skies' track peregrine falcon recovery in California 2Volunteer 'eyes on the skies' track peregrine falcon recovery in California 3Volunteer 'eyes on the skies' track peregrine falcon recovery in California 4Volunteer 'eyes on the skies' track peregrine falcon recovery in California 5
... Tom Corbett was honored today by the ... the Year Award in recognition of his leadership and commitment ... Pennsylvania . Corbett received the award ... Chicago, Ill. "This recognition from the ...
... R. Lewandowski, who opened with the line, "What if I ... with just refrigerator magnets and a laser pointer?", got raves ... team,s product, based on those common items, is a hand-held ... when digesting red blood cells. The Rapid Assessment of ...
... by Cornell University,s Creative Machines Lab has created a computer ... their squishy, muscle-like features in order to teach themselves to ... how nature builds complex animals from jellyfish to jaguars. ... evolve a diverse series of gaits and gallops. The ...
Cached Biology News:Governor Corbett Presented 2013 Biotechnology Industry Organization Governor of the Year Award 2Governor Corbett Presented 2013 Biotechnology Industry Organization Governor of the Year Award 3Hand-held device cheaply, quickly diagnosis malaria 2Hand-held device cheaply, quickly diagnosis malaria 3
... the MSn performance of the LTQ linear ... generate extensive structural information for the most ... Multiple dissociation techniques (PQD, ETD, CID) , ... , Fast polarity switching for high-sensitivity analysis ...
Request Info...
The Synergy HT utilizes a unique dual-optics design combined with monochromator wavelength selection to provide uncompromised performance in absorbance, fluorescence and luminescence reading modes. ...
... SYBR Green I nucleic acid gel stain ... that has bright fluorescence when bound to dsDNA ... for detecting dsDNA in gels using laser scanners ... acid stain has also found uses in capillary ...
Biology Products: